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POMC-derivedmelanocortinsinhibitfoodintake.Intheadultrodentbrain,POMC-expressingneuronsarelocatedinthearcuatenucleus
(ARC) and the nucleus tractus solitarius (NTS), but it remains unclear how POMC neurons in these two brain nuclei regulate feeding
behaviorandmetabolismdifferentially.Usingpharmacogeneticmethodstoactivateordepleteneurongroupsinseparatebrainareas,in
the present study, we show that POMC neurons in the ARC and NTS suppress feeding behavior at different time scales. Neurons were
activated using the DREADD (designer receptors exclusively activated by designer drugs) method. The evolved human M3-muscarinic
receptor was expressed in a selective population of POMC neurons by stereotaxic infusion of Cre-recombinase–dependent, adeno-
associatedvirusvectorsintotheARCorNTSofPOMC-Cremice.AfterinjectionofthehumanM3-muscarinicreceptorligandclozapine-
N-oxide (1 mg/kg, i.p.), acute activation of NTS POMC neurons produced an immediate inhibition of feeding behavior. In contrast,
chronicstimulationwasrequiredforARCPOMCneuronstosuppressfoodintake.Usingadeno-associatedvirusdeliveryofthediphthe-
riatoxinreceptorgene,wefoundthatdiphtheriatoxin–inducedablationofPOMCneuronsintheARCbutnottheNTS,increasedfood
intake,reducedenergyexpenditure,andultimatelyresultedinobesityandmetabolicandendocrinedisorders.Ourresultsrevealdiffer-
entbehavioralfunctionsofPOMCneuronsintheARCandNTS,suggestingthatPOMCneuronsregulatefeedingandenergyhomeostasis
byintegratinglong-termadipositysignalsfromthehypothalamusandshort-termsatietysignalsfromthebrainstem.
Introduction
POMCneuronsplaycriticalrolesinmaintainingnormalfeed-
ing behavior and energy homeostasis (Schwartz et al., 2000;
Morton et al., 2006). Genetic and pharmacological studies
have revealed that the activity of POMC neurons functions to
reduce appetite, enhance metabolism, and increase energy ex-
penditure.AblatingPOMCneuronsintheentirebrainormu-
tating the POMC gene causes obesity in rodents and humans
(Yaswen et al., 1999; Coll et al., 2004; Gropp et al., 2005; Xu et
al., 2005). Intraventricular administration of POMC-derived
melanocortins such as -melanocyte–stimulating hormone
(-MSH) or its analogs suppresses food intake within hours
(Fan et al., 1997).
In the adult rodent brain, a majority of POMC neurons are
locatedinthearcuatenucleus(ARC)ofthehypothalamus(Cone,
2005; Padilla et al., 2012). Moreover, melanocortin receptors are
richly expressed in the downstream stations targeted by ARC
POMCneurons(Cone,2005),suggestingthattheseneuronscon-
sistofafundamentalcomponentintheneuralcircuitunderlying
feeding inhibition. However, optogenetic stimulation of POMC
neurons in the ARC for 2 h does not inhibit food intake (Aponte
et al., 2011), implying that there are additional neuronal popula-
tions that mediate the acute inhibitory effect of melanocortin
signaling. In addition to the ARC, the nucleus tractus solitarius
(NTS) in the medulla also contains a substantial number of
POMC-expressing neurons (Bronstein et al., 1992; Padilla et al.,
2012). The exact functional significance of these two different
groups of POMC neurons has not been studied directly.
Inthisstudy,weexaminedthebehavioralfunctionsofPOMC
neurons by separately stimulating or ablating these two neuron
populations. We used the DREADD (designer receptors exclu-
sively activated by designer drugs) method for neuron activation
(Armbrusteretal.,2007;Alexanderetal.,2009).Thegeneencod-
ing the evolved human M3-muscarinic receptor (hM3Dq) was
targeted selectively into POMC neurons in the ARC or NTS with
aCre-inducibleadeno-associatedvirus(AAV)vectorthatcarries
a“double-floxed”invertedopenreadingframe(AAVDIO)(Ata-
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were activated remotely by injection of the hM3Dq ligand
clozapine-N-oxide (CNO). After discovering that feeding sup-
pression required stimulation of these two neuron groups at dif-
ferenttimescales,wewentontoinvestigatethenecessityofthese
neuronsinmaintainingenergyhomeostasis.Asimilarstrategyof
AAV vector design was used to express diphtheria toxin receptor
(DTR) in POMC neurons in the ARC or NTS for later neuron
lesion with the injection of DT (Buch et al., 2005; Gropp et al.,
2005; Luquet et al., 2005). Our results indicate that ablating
POMC neurons in the ARC but not the NTS produces obesity
and metabolic disorders. These findings highlight the functional
heterogeneity among brain POMC neurons, suggesting that the
ARC and NTS POMC neurons contribute to maintaining long-
termenergyhomeostasisandcontrollingshort-termfoodintake,
respectively.
MaterialsandMethods
Mice. Animal care and use conformed to institutional guidelines of the
National Institute of Biological Sciences (Beijing, China) and to govern-
mental regulations. All experiments were performed on adult (8–16
weeks of age) POMC-Cre mice of either sex expressing Cre recombinase
under POMC promoter control [strain name Tg(Pomc1-cre)16Lowl/J,
The Jackson Laboratory] (Balthasar et al., 2004). Cre recombinase in
these mice has been shown to mediate recombination of floxed alleles
efficiently in neurons within the ARC and NTS (Balthasar et al., 2004;
Huo et al., 2006). In the ARC of these mice, Cre recombinase drives the
expression of marker proteins that colocalize with POMC immunoreac-
tivity. In the NTS, the distribution pattern of Cre-expressing neurons
resembles that of neurons expressing POMC mRNA (Balthasar et al.,
2004; Huo et al., 2006), but the precise identity of Cre-expressing neu-
ronshasnotbeentestedwithPOMCimmunohistochemistry.Micewere
housed under controlled temperature (22–25°C) and 12 h light/dark
cycles (light time, 9:30 P.M. to 9:30 A.M.) with standard chow diet (4%
fatSPFRodentFeed,BejingKeaoXieliFeedCo.)andadlibitumdrinking
water.
AAV vectors for hM3Dq or DTR expression. We used Cre-inducible
AAV vectors with an AAV DIO carrying the specific genes in the anti-
sense orientation (Atasoy et al., 2008). The coding sequence of hM3Dq-
2A-mCherry, DTR, or mCherry was inserted into an AAV DIO vector
with a CMV early enhancer/chicken -actin (CAG) promoter (see Figs.
1A,B, 4A). All coding sequences were in a 3 to 5 orientation relative to
the promoter. The vectors were then sequenced and packaged in AAV
serotype 2/9 vectors consisting of AAV2 ITR genomes pseudotyped with
AAV9 serotype capsid proteins. AAV vectors were replicated in HEK293
cells with the triple plasmid transfection system purified by cesium
chloride-density gradient centrifugation and desalination via dialysis
againstaphysiologicalbuffer(Duanetal.,2001),resultinginAAVvector
titers of 10
9 particles/l.
Stereotaxic virus injection. Mice were injected with atropine (0.05 mg/
kg, i.p.) and anesthetized with pentobarbital (80 mg/kg, i.p.), placed in a
temperature-controlled stereotaxic holder (BrainKing Biotech), and a
small hole was opened in the skull. Pulled glass pipettes (20 m tip
diameter)werefilledwithAAVandinsertedintospecificbrainareas.For
the ARC, AAV vectors (500 or 1000 nl) were infused with pressure (co-
ordinate AP/DV/ML  1.7/5.5/0.2 mm; infusion speed  23 nl/
min; Nanoliter 2000 Injector, WPI). For the NTS, 500 nl of vector was
injected into the medulla (coordinate  8.4/3.3/0 mm). To activate
neurons, AAV DIO hM3Dq-2A-mCherry vectors were injected into the
ARC or NTS of POMC-Cre mice, which for simplicity are referred to as
ARC
hM3Dq mice and NTS
hM3Dq mice, respectively. To ablate neurons,
AAVDIODTRvectorswereinjectedintotheARCorNTSofPOMC-Cre
mice (referred to as ARC
DTR mice and NTS
DTR mice, respectively) and
DT was injected 14 d later. To confirm lesion effects in the NTS, AAV
DIO mCherry vectors were injected into the NTS of NTS
DTR mice after
behavioral studies. For control, AAV DIO mCherry virus was injected
into the ARC or NTS of POMC-Cre mice (referred to as ARC
mCherry
mice and NTS
mCherry mice, respectively). Mice were allowed to recover
in individual cages for at least 2 weeks before the behavioral assays.
Measurement of food intake, meal pattern, body weight, and body mass
composition.Tomeasurefoodintake,eachtestcagewasequippedwithan
individual food station that was placed on a digital scale (Zhenquan
Technology). Food weight was recorded online through RS232 ports.
ARC
hM3DqmiceorNTS
hM3Dqmicewerefirstinjectedwithsalineduring
the first2d( 1l/g body weight, i.p.) at dark onset. They were then
suppliedwithasingledoseofCNO(1mg/kgbodyweightinsalinei.p.;1
l/g)atdarkonsetduringthenext2d.Ondays5and6,miceweregiven
two injections of CNO, first at dark onset and then 5 h later. After the
application of either saline or CNO, cumulative food intake at different
time points (2, 5, 8, 10, 12, and 24 h) were measured. The same proce-
dureswereperformedinARC
mCherrymiceandNTS
mCherrymicetocon-
trol the effect of CNO. The values of meal number and meal size were
quantified using methods described previously (Zorrilla et al., 2005).
Briefly,foodintakeafterdarkonsetwasrecordedevery5minfor5h.The
minimalintermealintervalwas15minandthecriterionofminimalmeal
size was 50 mg. To examine the effects of chronic CNO application on
ARC
hM3Dq mice and NTS
hM3Dq mice, animals received saline injections
every 5 h during the first 2 d, then CNO injections every5hf o r3d .
TokillPOMCneurons,ARC
DTRmiceandNTS
DTRmiceweregivena
singleinjectionofDT(50g/kg,i.p.).ARC
mCherrymiceandNTS
mCherry
mice were provided with the same dose of DT as a control. The body
weights and food intakes of all DT-treated mice were monitored on a
daily basis for 4 weeks. One month after DT injection, whole-body mass
compositionwasexaminedwithabenchtopnuclearmagneticresonance
analyzer (Minispec Live Mouse Analyzer, Bruker).
Glucose tolerance tests and serum assays. One month after DT applica-
tion, mice were fasted with free access to water 3 h before light onset.
After 16 h of fasting, the end of the tail was cut horizontally with a razor
blade and a small drop of blood was collected with gentle massaging for
the measurement of baseline blood glucose level using a blood glucose
meter (One Touch, Johnson & Johnson Medical). Mice were then given
a20%glucosesolution(2g/kgbodyweight,i.p.)andbloodglucoselevels
were further sampled at the time points of 15, 30, 60, 90, and 120 min.
Lipidmetabolismandcorticosteronelevelsweremeasured40dafter
DT injections. After overnight fasting, mice were anesthetized with iso-
flurane. Blood was drawn from the retrobulbar intraorbital capillary
plexus and serum was then separated by centrifugation. Serum levels of
total cholesterol, triglycerides, high-density lipoprotein cholesterol, and
low-densitylipoproteincholesterolwereanalyzedbytheInstituteofLab-
oratory Animal Sciences at the Chinese Academy of Medical Sciences.
The serum corticosterone levels were measured with a commercial cor-
ticosterone ELSA kit (catalog #ADI-900-097, Enzo Life Sciences).
Measurement of locomotor activity and oxygen consumption. The loco-
motor activity level of each mouse was quantified by measuring the total
traveldistanceusingamethoddescribedpreviously(Bjurselletal.,2008;
Gong et al., 2011; Klockener et al., 2011). Twenty days after DT treat-
ment, mice were placed in a test cage (30  30 cm) with an overhead
infrared camera (KVS-5096S, Wanzhongxin Technology). Animal
movementwasvideotapedat5fpsandthehorizontallocomotoractivity
was analyzed online with a custom-written MATLAB program. The
travel distance of an individual mouse was clustered into different time
periods in a day and then averaged across the test period of 6 d. Oxygen
consumption was measured with an open-circuit calorimeter system
(AccuScanInstruments).Themeasurementwastakenevery2minfor2h
during light cycles with room air as a reference and an air flow to the
chambers of 0.5 l/min. Data were normalized to body weight.
Histology, immunostaining, and imaging. For c-Fos immunostaining,
mice received an i.p. injection of either saline or CNO (1 mg/kg). Ninety
minuteslater,micewereanesthetized(300mg/kgpentobarbital,i.p.)and
perfusedtranscardiallywithcoldsalineand4%paraformaldehydeinthe
PBS with 0.2% picric acid. Brains were extracted and postfixed in 4%
paraformaldehydeovernightat4°Candcryoprotectedwith30%sucrose.
Coronal sections (30–40 m) were cut with a cryostat (CR 1900, Leica)
and mounted on glass slides. Brain sections were reacted with rabbit
anti-POMCantibody(1:400;lot#01181-3,PhoenixPharmaceuticals)or
rabbit anti–c-Fos antibody (1:200; produce #PC38, EMD Chemicals)
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antibody (1:500, lot #103581, Jackson ImmunoResearch) overnight at
4°C.Fluorescentimageswereacquiredwithaconfocalmicroscope(Digi-
talEclipse A1, Nikon) and processed with Adobe Photoshop. Cell num-
bers were counted manually under an epifluorescence microscope.
Electrophysiological recordings. The method of electrophysiological re-
cording from brain slices has been described in detail previously (Ren et
al., 2011). Briefly, adult mice were deeply anesthetized and decapitated.
Brain sections were cut with a Vibratome (model #VT1000S, Leica) in
ice-cold, oxygenated artificial CSF (aCSF) containing 125 mM NaCl, 2
mM CaCl2, 2.5 mM KCl, 1.3 mM MgCl2, 1.3 mM NaH2PO4, 1.3 mM Na-
ascorbate, 0.6 mM Na-pyruvate, 25 mM NaHCO3, and 20 mM glucose,
andthenincubatedinwarmoxygenatedaCSF(34°C)for1h.Brainslices
were transferred into the recording chamber and superfused (2 ml/min)
withoxygenatedaCSFatroomtemperature(22–25°C).Whole-cellpatch
recordings or cell-attached patch recordings were performed with a
computer-controlled amplifier (MultiClamp 700B, Molecular Devices).
Whole-cell patch-clamp recording pipettes (4–7 M) were backfilled
withinternalsolutioncontainingthefollowing:130mMK-gluconate,10
mM HEPES, 0.6 mM EGTA, 5 mM KCl, 3 mM Na2ATP, 0.3 mM Na3GTP,
Figure1. SelectiveactivationofPOMCneuronsintheARCorNTSusingDREADDtechnology.A,B,DesignsforAAVDIOhM3Dq-2A-mCherry(A)andAAVDIOmCherry(B)vectors.L-ITR,Left
invertedterminalrepeat;CAG,CMVenhancer/chicken-actinpromoter;WPRE,woodchuckhepatitisvirusposttranscriptionalregulatoryelement;andR-ITR,rightinvertedterminalrepeat.C,
StereotaxicinfusionofAAVDIOhM3Dq-2A-mCherryvectorsintotheARCofPOMC-CremicelabelsneuronsinthebilateralARC.3V,Thirdventricle;ME,medianeminence;andD,dorsal.D,Vector
injectionintothemedullalabelsapopulationofneuronsintheNTS.cc,Centralcanal.E,SelectiveexpressionofhM3Dq/mCherry(red)inPOMC-immunopositiveneurons(green)intheARC.F,
Whole-cellcurrent-clamprecordingrevealsthatanhM3Dq/mCherry
	POMCneuronintheARCwasexcitedbypressureinjectionofhM3DqreceptorligandCNO(horizontalbar).G,Rawrecording
traceofasinglecellandgroupdatashowthatCNOremainseffectiveindepolarizinghM3Dq/mCherry
	POMCneuronsintheARCinthepresenceoftetrodotoxin.Errorbarsindicatemean	SEM.
H,CNOevokesvigorousfiringofactioncurrentsfromhM3Dq/mCherry
	POMCneuronsintheNTS.Therightpanelshowstheaverageperistimulustimehistogramofspikefiringfrequencyoffive
NTSPOMCneurons.I,AfterunilateralexpressionofhM3Dq(red)intheARC,CNOinjection(1mg/kg,i.p.)inducesc-Fosexpression(green)intheipsilateralbutnotthecontralateralARC.Rightpanel
showstheoverlayofmCherrysignalsandPOMCimmunoreactivitywithinthedashedrectangleareainthetwoleftpanels.J,c-FosimmunostainingconfirmsthatCNOactivatesNTSneuronsinvivo.
K, In both the ARC and NTS, approximately half of the hM3Dq-expressing POMC neurons express c-Fos in response to a single injection of CNO. L, More than half of c-Fos
	 neurons lack clear
hM3Dq/mCherryexpression.
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tance(20–30M)wascompensatedforinallwhole-cellrecordings.The
pipettes for cell-attached recording (3–4 M) contained bath solution
and the seal resistance was 200 M. hM3Dq/mCherry
	 POMC neu-
rons were targeted in the ARC or NTS under the visual guidance of red
fluorescent signals using an upright microscope (Examiner Z1, Zeiss).
CNO dissolved in aCSF was released to the recording area with a small
pressure using an 8-channel drug-delivery system (MPS-1, Inbio Life
Science Instrument). Traces were low-pass filtered at 2.6 kHz and digi-
tized at 10 kHz (DigiData 1440, Molecular Devices).
Statistical analysis. Data analysis was performed with MATLAB
(MathWorks).ThettestandANOVAwereusedtodeterminethesignif-
icance of differences between groups, and p 
 0.05 was considered as
significant. Group data are represented as means 	 SEM in the figures.
Results
SelectiveactivationofPOMCneuronsintheARCor NTS
ToactivatePOMCneuronsselectively,AAVvectorswereusedto
express the hM3Dq receptor, which has a high affinity for the
pharmacologically inert ligand CNO but not endogenous neu-
rotransmitters (Alexander et al., 2009). The hM3Dq coding se-
quence was packaged into a Cre-recombinase–dependent AAV
vector that enabled bicistronic expression of the red fluorescent
protein mCherry (AAV DIO hM3Dq-2A-mCherry; Fig. 1A).
AAV DIO mCherry vectors were used as the control (Fig. 1B).
Two weeks after stereotaxic infusion of AAV DIO hM3Dq-2A-
mCherry viral vectors into the ARC or the NTS of POMC-Cre
mice, mCherry expression was detected exclusively in either of
these two brain areas (Fig. 1C,D). Red fluorescent mCherry sig-
nals were colocalized with POMC immunoreactivity in the ma-
jority(95%)oftheneuronsintheARC(Fig.1E).Theefficiency
of hM3Dq/mCherry expression was comparable among POMC
neurons in the ARC and NTS. Using labeling of bicistronically
expressed mCherry as a marker, clear hM3Dq expression was
observed in 70% of POMC-immunopositive neurons in the
entire ARC of ARC
hM3Dq mice (2050  254 hM3Dq/mCherry
	
neuronsofatotalof3000POMC
	neurons;meanSEM;n
9 mice). Similarly, 77% of POMC neurons in the NTS
expressed hM3Dq (311  34 hM3Dq/mCherry
	 cells of the re-
ported total of 400 POMC neurons; n  11 NTS
hM3Dq mice)
(Cone, 2005).
To determine whether CNO could activate POMC neu-
rons, targeted whole-cell recordings were made from hM3Dq/
mCherry
	 POMC neurons in the ARC of brain slices. CNO
administration(10M)depolarizedthesecellssignificantly,from
57.12.0mVto45.72.4mV(p
0.01;pairedttest;n
5 cells) and increased the firing frequency of action potentials
from 0.04  0.04 Hz to 1.30  0.30 Hz (p 
 0.05; paired t test;
n  5 cells; Fig. 1F). CNO, but not the aCSF control, remained
capable of depolarizing ARC POMC neurons in the presence of
thesodiumchannelblockertetrodotoxin(1M;**p
0.01;ttest
betweenCNOandaCSFcontrol;n5cells;Fig.1G),suggesting
thatCNOexcitedARCPOMCneuronsdirectlywithoutsynaptic
input. Similarly, cell-attached recordings demonstrated that
CNOactivatedhM3Dq/mCherry
	POMCneuronseffectivelyin
theNTS(actionpotentialfiringfrequency1.50.9Hzbefore
CNO and 3.3  1.1 Hz during CNO; p 
 0.05; paired t test; n 
5 cells; Fig. 1H).
Thepatternofneuronalactivationwasthenexaminedinvivo.
CNO (1 mg/kg, i.p.) was injected into POMC-Cre mice with
unilateral hM3Dq/mCherry expression in the ARC and c-Fos
expression was used as an indicator of neuronal activity. The
number of c-Fos
	 cells (1000) in the ipsilateral ARC was ap-
proximatelyninefoldthatinthecontralateralside(Fig.1I).Inthe
NTS, the number of c-Fos
	 neurons in NTS
hM3Dq mice (300
cells)wassimilar,at9timesofthatinNTS
mCherrycontrolmice
(n  5 mice of either group; Fig. 1J). In both the ARC and NTS,
the overall distribution pattern of c-Fos
	 cells resembled that of
hM3Dq/mCherry
	 POMC cells. By examining the dual-color
fluorescentsignalsofatotalof7678hM3Dq/mCherry
	neurons
from the ARC of six ARC
hM3Dq mice and 1392 cells from the
NTS of five NTS
hM3Dq mice, approximately half of hM3Dq/
mCherry
	 neurons were found to be c-Fos positive in these two
nuclei(53.92.6%intheARCand49.71.1%intheNTS;Fig.
1K). However, in both areas, more than half of the c-Fos
	 neu-
rons lacked clear hM3Dq/mCherry expression (55.7  1.9% in
theARCand56.43%intheNTS;Fig.1L),likelybecauseCNO
triggered c-Fos expression in nearby non-POMC neurons
through synaptic connections from POMC neurons.
AcutefeedingsuppressionbyactivatingPOMCneuronsin
theNTSbutnotthe ARC
After establishing the validity of pharmacogenetic activation of
POMC neurons, the effect of CNO injection on food intake and
body weight of ARC
hM3Dq mice that expressed hM3Dq in the
bilateralARCwasanalyzed(Fig.2A,B;n9mice).Salineinjec-
tion into ARC
hM3Dq mice was used as the self-control (Fig. 2A)
and CNO injection into ARC
mCherry mice was used as an addi-
tional control (Fig. 2C; n  8 mice). A two-way ANOVA was
conducted to compare the effect of CNO injections and the du-
Figure2. ChronicbutnotacuteactivationofARCPOMCneuronsinhibitsfeedingandbodyweight.A,NeitherasingleCNOinjection(CNO)nortwoinjectionsat5hintervals(CNO2)affectfood
intakeofARC
hM3Dqmice.B,AcuteCNOadministrationdoesnotaffectthebodyweightofARC
hM3Dqmice.C,CNOhasnoeffectonthefoodintakeofARC
mCherrycontrolmice.D,MultipleCNOinjections
for3dsuppressthefoodintakeandreducethebodyweightofARC
hM3Dqmice.Significanteffectswereobserved1dafterchronicCNOadministration(*p
0.05;**p
0.01;pairedttestbetween
salinecontrolandCNOinjections;n5ARC
hM3Dqmice).Asterisksabovethelinesindicatesignificanteffectsonfoodintakeandthosebelowindicateeffectsonbodyweight.Errorbarsindicate
mean	SEM.
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on food intake after either a single CNO injection or 2 injections
in5hintervals(ANOVA:drugeffectF(2,96)0.092,p0.91n
9mice;Fig.2A).Thedurationwastheonlydeterminingfactoron
food intake (F(3,96)  157.7, p 
 0.001), and acute CNO admin-
istrations did not alter the body weight of ARC
hM3Dq mice (p 
0.96 and 0.95; paired t test between saline and CNO and that
between saline and CNO  2, respectively; n  9 mice; Fig. 2B).
Similar observations were made for ARC
mCherry control mice
(ANOVA: drug effect F(2,84)  0.38, p  0.69; n  8 mice; Fig.
2C). However, the amount of daily food intake and body weight
of ARC
hM3Dq mice were significantly reduced after chronic acti-
vation of ARC POMC neurons with consecutive CNO injections
f o r3d( 5hinterval between injections; ANOVA on body weight
ofARC
hM3Dqmice:drugF(2,32)5.5,p
0.01;timeF(2,32)1.4,
p  0.25; interaction between drug and time F(3,32)  5.23, p 

0.01; ANOVA on food intake of ARC
hM3Dq mice: drug F(2,32) 
3.5, p 
 0.05; time F(2,32)  0.27, p  0.76; interaction between
drug and time F(3,32)  2.16; p  0.11; n  5 mice; Fig. 2D). As a
control, chronic CNO injection did not change the food intake
nor body weight of ARC
mCherry mice significantly (ANOVA on
bodyweight of ARC
mCherry control mice: drug F(2,32)  0.07, p 
0.93; time F(2,32)  0.10, p  0.91; interaction between drug and
time F(3,32)  0.36; p  0.79; ANOVA on food intake of
ARC
mCherry control mice: drug F(2,32)  0.12, p  0.89; time
F(2,32)  1.68, p  0.20; interaction between drug and time
F(3,32)  0.52, p  0.67; n  5 mice). These observations suggest
that long-term but not acute activation of ARC POMC neurons
suppresses animal feeding behavior.
Interestingly, acute activation of NTS POMC neurons pro-
duced immediate inhibition of feeding behavior. Within the first
2 h of CNO injection, NTS
hM3Dq mice exhibited an 70% de-
crease in food intake (n  8 mice; Fig. 3A). A significant inhibi-
tory effect on the amount of accumulative food consumption
lasted for up to 5 h (ANOVA: drug F(2,84)  5.05, p 
 0.01; time
F(3,84)97.52,p
0.001;BonferroniposthoctestsafterANOVA:
**p
0.01;***p
0.001;n8mice;Fig.3A).Mealnumberand
meal size were also reduced (*p  0.034; ***p 
 0.001; paired t
test; n  8 mice; Fig. 3B,C). The effective duration of CNO is
consistentwithanearlierstudyontheeffectivedurationofinvivo
CNO application (Alexander et al., 2009). CNO injections into
NTS
mCherry mice given as a control did not affect food intake
(ANOVA: drug F(2,60)  3.1, p  0.06; time F(3,60)  260.8, p 

0.001; interaction between drug and time F(6,60)  1.2, p  0.35;
n6mice;Fig.3D).AsecondCNOinjection5haftertheinitial
injection prolonged the inhibition for at least an additional 3 h
(***p 
 0.001; post hoc tests after ANOVA; n  8 mice; Fig. 3A),
but NTS
hM3Dq mice compensated for the inhibited food intake
during the next few hours (ANOVA: interaction between drug
andtimeF(12,147)4.13,p
0.001;Bonferroniposthoctestsafter
ANOVA:**p
0.01;***p
0.001;n8mice;Fig.3E).Thisled
to an apparently normal amount of cumulative food intake on a
daily basis and normal body weights for NTS
hM3Dq mice (p 
0.84 and 0.81 for paired t test between saline and CNO and that
between saline and CNO  2, respectively; n  8 mice; Fig.
3A,F). Locomotor activity was measured to determine whether
thesuppressionoffoodintakewasassociatedwithareductionin
activity or arousal levels. CNO injections did not change the lo-
comotor activity of NTS
hM3Dq mice (2-way ANOVA: drug
F(2,75)0.22,p0.80;timeF(4,75)73.4,p
0.001;interaction
between drug and time F(8,75)  0.1; p  0.99; n  6 mice; Fig.
3G), suggesting that acute activation of NTS POMC neurons did
not change motor ability nor arousal levels.
When NTS
hM3Dq mice were given chronic stimulation with
multiple CNO injections for 3 d, daily food intakes and body
weights were decreased significantly for the first day but then
rebounded during the following days (ANOVA on food intake:
drug F(2,32)  11.15, p 
 0.001; time F(2,32)  5.75; p 
 0.01;
Figure3. ActivatingPOMCneuronsintheNTSsuppressesfeedingbehaviorimmediately.A,AmountoffoodintakeatdifferenttimepointsafterfirstCNOinjectionintoNTS
hM3Dqmice.Food
intakeissignificantlyreducedwithin2–5hofthefirstCNOinjection.AsecondCNOinjection5haftertheinitialinjectionsignificantlyinhibitsfoodintakeforanadditional3h.B,C,AcuteCNO
administrationreducesthemealsize(B)andmealnumber(C)ofNTS
hM3Dqmicesignificantly.D,CNOdoesnotaffectthefoodintakeofNTS
mCherrymice.E,Foodintakewithindifferenttimeperiods
after the first CNO injection. F, No effect by acute CNO administration on the body weight of NTS
hM3Dq mice. G,CNO administration does not change the level of locomotor activity within
differenttimeperiodsafterthefirstCNOinjection.H,EffectsofchronicCNOapplicationonthedailyfoodintakeandbodyweightofNTS
hM3qmice(*p
0.05;**p
0.01;pairedttest
betweendaysofsalinecontrolandthoseofCNOinjection;n  5mice).Asterisksabovethelinesindicatesignificanteffectsonfoodintakeandthosebelowindicateeffectsonbody
weight.Errorbarsindicatemean	SEM.
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ANOVA on bodyweight: drug F(2,32)  15.0, p 
 0.001; time
F(2,32)  0.59, p  0.56; interaction between drug and time
F(3,32)0.68;p0.57;n5mice;Fig.3H).Incontrast,thefood
intakes and body weights of NTS
mCherry control mice were not
affected by chronic CNO application (ANOVA on food intake:
drug F(2,32)  0.41; p  0.67; time F(2,32)  1.79; p  0.18; inter-
action between drug and time F(3,32)  0.71; p  0.55; ANOVA
onbodyweight:drugF(2,32)0.76,p0.48;timeF(2,32)0.30,
p  0.75; interaction between drug and time F(3,32)  0.25, p 
0.86; n  5 mice). The data from NTS
hM3Dq mice thus indicate
that the activity of NTS POMC neurons is responsible for acute
but not chronic inhibition of feeding behavior.
SelectiveablationofPOMCneuronsintheARCbutnotthe
NTScauses obesity
The necessity of ARC or NTS POMC neurons in regulating en-
ergy homeostasis was investigated by ablating these two neuron
populations separately. AAV DIO DTR viral vectors were in-
fusedintotheARCortheNTSofPOMC-Cremice(ARC
DTRand
NTS
DTR mice, respectively) to express DTR in POMC neurons
(Fig.4A).Figure4B,left,showstherepresentativeeffectofkilling
ARCPOMCneuronsafteraninjectionofDT(50g/kg,i.p.)into
an ARC
DTR mouse. By counting the number of neurons with
POMCimmunoreactivityintheARC,DTinjectionwasfound
to kill 60–100% of POMC neurons in the ARC (n  22 mice).
Due to the difficulty in labeling NTS POMC neurons with
immunostaining methods (Bronstein et al., 1992; Huo et al.,
2006), AAV DIO mCherry vectors was delivered to label
POMC neurons in the NTS after behavioral tests. DT reduced
the number of mCherry
	 neurons drastically in the NTS of
NTS
DTR mice (Fig. 4B, right), whereas it did not induce any
apparentchangeinthedistributionpatternofmCherry
	neu-
rons in NTS
mCherry control mice (data not shown). Therefore,
POMC neurons in either the ARC or NTS could be separately
ablated by taking the approach of expressing DTR with Cre-
dependent AAV vectors.
Ablation of POMC neurons in the ARC resulted in obesity in
a substantial number of ARC
DTR mice (Fig. 4C). The extent of
body weight gain was negatively correlated with the number of
surviving POMC neurons (Pearson’s correlation coefficient r 
0.81;p
0.001),anditappearsthat500cellsintheARCwere
sufficient to maintain normal body weight (Fig. 4D). The
ARC
DTR mice with 
500 POMC neurons in the ARC consumed
significantly more food than the ARC
mCherry control mice
(ANOVA: lesion F(3,675)  40.14, p 
 0.001; time F(26,675) 
1.523, p  0.056; interaction between lesion and time F(78,675) 
3.148, p 
 0.001; Bonferroni post hoc tests after two-way
ANOVA: p 
 0.01 for day 1 and p 
 0.001 thereafter between
ARC
DTR and ARC
mCherry mice; Fig. 4E). Lesions of ARC POMC
neurons also resulted in a steady increase in body weight
(ANOVA: lesion F(3,1377)  35.23, p 
 0.001; time F(26,1377) 
26.91,p
0.001;interactionbetweenlesionandtimeF(78,1377)
25.93, p 
 0.001. Bonferroni post hoc tests after two-way
ANOVA: p 
 0.01 for days 6 and 7 and p 
 0.001 after day 7
between ARC
DTR and ARC
mCherry mice; Fig. 4F).
In addition to increased food intake, energy expenditure was
reducedintheobeseARC
DTRmice.Theirlocomotoractivitywas
significantly lower than that of ARC
mCherry control mice during the
dark phase of the light cycles (ANOVA: lesion F(1,28)  130, p 

0.001;dark/lightphaseF(1,28)37.3,p
0.001;interactionbetween
lesionanddark/lightphaseF(1,28)20.8,p
0.001;Bonferronipost
hoc tests after two-way ANOVA: p 
 0.001 for tests between
ARC
DTR and ARC
mCherry mice for dark phase; p  0.05 for light
phase;n8miceforeachgroup;Fig.5A).Consistently,theoxygen
metabolism of DT-treated ARC
DTR mice was lower than that
of ARC
mCherry control mice (***p 
 0.001; between-group t
test, Fig. 5B).
The ARC
DTR mice had markedly higher body fat mass and
lower lean mass (***p 
 0.001; t test between ARC
DTR and
Figure4. AblatingPOMCneuronsintheARCbutnottheNTScausesobesityandhyperphagia.A,DesignforAAVDIODTRvectors.B,ImagesillustratingthatDTinjectionseliminatePOMCneurons
intheARCofARC
DTRmice(left)andtheNTSofNTS
DTRmice(right).POMCimmunostaining(green)wasperformedtoconfirmthelesioneffectintheARC.AAVDIOmCherrywasinjectedintoNTS
DTR
micetoconfirmthekillingofPOMCneuronsintheNTSbymCherrylabeling.C,AfterDTinjections,ARC
DTRmicebutnotcontrolARC
mCherrymicedisplayclearobesity.D,Theeffectofbodyweightgain
isnegativelycorrelatedwiththenumberofremainingPOMCneuronsintheentireARC.Eachsquarerepresentsdatafromasinglemouse.E,DTinjectionsincreasedailyfoodintakesignificantlyfor
ARC
DTRmicebutnotNTS
DTRmice.F,PlotsofbodyweightgainformicewithablationsofPOMCneuronsintheARCortheNTS.EliminatingPOMCneuronsintheARCbutnottheNTSresultsin
significantweightgain.Errorbarsindicatemean	SEM.
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mCherry mice; Fig. 6A) and exhibited a broad spectrum of met-
abolic and endocrine disorders associated with obesity. ARC
DTR
mice had significantly higher levels of total serum cholesterol, high-
density lipoprotein cholesterol, and low-density lipoprotein choles-
terol serum lipids (*p 
 0.05; t tests between ARC
mCherry and
ARC
DTR mice injected with DT) but not triglycerides (p  0.41; t
test; Fig. 6B). These mice showed fasting hyperglycemia and im-
pairedglucosetolerance(ANOVA:lesionF(3,132)21.1,p
0.001;
time F(5,132) 21.5, p
0.001; interaction between lesion and time
F(15,132)  1.4, p  0.17. Bonferroni post hoc tests after two-way
ANOVA: p  0.05 at 0 min; p 
 0.01 at 15 min; p 
 0.001 during
30–120 min for comparison between ARC
DTR and ARC
mCherry
mice; Fig. 6C). Moreover, ablating ARC POMC neurons reduced
plasma corticosterone levels significantly (*p 
 0.05; t test between
ARC
DTR and ARC
mCherry mice; Fig. 6D). Similar DT injection into
16 NTS
DTR mice was performed and complete ablation was ob-
servedinsevenofthem.Thebodyweightof
these 16 NTS
DTR mice resembled that of
DT-injectedNTS
mCherrycontrolmice.Data
for the seven completely lesioned animals
are shown in Figures 4 and 6. Ablating NTS
POMC neurons did not affect food intake
(Fig.4E),bodyweight(Fig.4F),bodycom-
position, lipid and glucose metabolism, or
corticosterone levels (Fig. 6). Therefore,
POMC neurons in the ARC but not in the
NTS are necessary for maintaining normal
food intake, metabolism, and body weight.
Discussion
In this study, we examined the behavioral
functions of POMC neurons in the ARC
andNTSbyselectivelymanipulatingthese
two neuronal populations with pharma-
cogenetic approaches. Chronic but not
acute activation of ARC POMC neurons
reduced food intake. Moreover, ablating
these neurons resulted in hyperphasia,
obesity, and metabolism disorders. In
contrast,acutestimulationofNTSPOMC
neurons rapidly suppressed feeding, but
killing these neurons did not produce any
obvious changes in feeding behavior or
body weight. These results indicate that
POMCneuronsintheARCandNTSplay
different roles in regulating feeding be-
havior and metabolism. Specifically, our
observations are consistent with the
model suggesting that the activity of ARC
POMCneuronsiscriticalformaintaining
long-termenergyhomeostasis,butthatof
NTS POMC neurons contributes to short-term feeding control
in response to satiety signals.
Previous genetic and pharmacological studies have estab-
lishedtheimportantfunctionsofPOMCsignalsintheregulation
of feeding behavior and energy homeostasis (Yaswen et al., 1999;
McMinn et al., 2000; Challis et al., 2004). However, it has been
challenging to determine the functions of separate popula-
tions of POMC neurons in the ARC and NTS of adult animals.
POMC is expressed dynamically in numerous brain areas in the
developing mouse brain (Padilla et al., 2010; Padilla et al., 2012).
Therefore, knocking out the POMC gene may alter neural cir-
cuitsthatarenotdirectlyrelatedtofeedingregulationintheadult
brain. Similarly, many non-POMC neurons in the adult may be
ablated by taking the traditional approach of crossing POMC-
Cre mouse with the iDTR mouse line. The pharmacogenetic ap-
proaches in the present study have several advantages that
overcome the technical limits of prior studies. Stereotaxic viral
genedeliveryintotheadultbrainavoidedthepotentialoff-target
effect in transgenic animals that drives gene expression from the
time of gestation (Padilla et al., 2012). More importantly, sepa-
rate manipulations allowed us to probe the behavioral functions
of POMC neurons selectively in the ARC and NTS. Finally, acti-
vation and lesion facilitated the study of the sufficiency and ne-
cessity of adult POMC neurons in behavioral regulation.
Figure5. AblatingPOMCneuronsintheARCreduceslocomotoractivityandenergyexpen-
diture.A,DTadministrationreducesthelocomotoractivitylevelofARC
DTRmicesignificantly
duringthedarkbutnotthelightphases.B,DTlesionofARCPOMCneuronssignificantlyreduces
animaloxygenconsumptioninametaboliccage.Errorbarsindicatemean	SEM.
Figure6. TheeffectsofablatingPOMCneuronsonmetabolism.A,AblatingPOMCneuronsintheARCbutnottheNTSincreases
thepercentageoffatmassandreducesthepercentageofleanmasssignificantly1monthafterDTtreatment.B,ObeseARC
DTRand
DT mice exhibit significantly higher levels of serum total cholesterol (CHO), high-density lipoprotein cholesterol (HDL-C), and
low-densitylipoproteincholesterol(LDL-C).Theleveloftriglycerides(TGs)inthesemiceiscomparabletothatincontrolanimals.
C, Ablating POMC neurons in the ARC but not the NTS produces glucose intolerance. D, Obese ARC
DTR and DT mice exhibit
significantlylowerserumcorticosteronelevel.Errorbarsindicatemean	SEM.
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behavioralfunctionsofthecentralmelanocortinsystem.Consis-
tentwithrecentoptogeneticstimulationofARCPOMCneurons
(Aponte et al., 2011), we have shown that feeding suppression
wasproducedonlybylong-term(overaday)butnotacutestim-
ulation (several hours) of these neurons. In addition, we have
foundthatselectivelesionsofPOMCneuronsintheARCbutnot
the NTS resulted in obesity, lower energy expenditure, and nu-
merous metabolic and endocrine disorders that are typically as-
sociated with obesity. The behavioral effects of ablating POMC
neurons in the ARC alone resembled the obesity phenotype pro-
ducedbyremovingPOMCneuronsintheentirebrain(Groppet
al., 2005), indicating that ARC but not NTS POMC neurons are
criticalformaintainingnormalbodyweight.Selectiveexpression
of the leptin receptor in brain POMC neurons increases the ac-
tivitylevelofthedb/dbmicethatlackfunctionalleptinreceptors
(Huo et al., 2009). Consistently, we found that ablating POMC
neurons in the ARC reduced animal locomotor activity and
oxygen consumption, suggesting that these neurons control
energy homeostasis by both reducing food intake and increas-
ing energy expenditure. ARC POMC neurons are activated by
leptin and glucose (Cowley et al., 2001; Ibrahim et al., 2003;
Parton et al., 2007). These neurons may modulate feeding-
andactivity-relatedneuralcircuitsbyrespondingtoslowmet-
abolic cues in the hypothalamus.
Another key finding of this study is that acute activation of
NTS POMC neurons leads to immediate suppression of food
intake. Many neurons in the NTS of the medulla express POMC
mRNAandarebelievedtosynthesizePOMCpeptides(Bronstein
etal.,1992).BydeliveringCre-dependentAAVvectors,wefound
that POMC-Cre mice can be used to express the CNO receptor
hM3Dq selectively in the putative POMC neurons in the NTS.
Acute stimulation of NTS but not ARC POMC neurons was ca-
pable of suppressing feeding behavior, suggesting that the rapid
inhibitoryeffectofmelanocortinsmightbemediatedbytheneu-
ralcircuitsdownstreamofNTSPOMCneurons(Fanetal.,1997).
Electrical stimulation of vagal afferent fibers has been found to
induce EPSCs directly in NTS POMC neurons (Appleyard et al.,
2005). In addition, gastric distention and i.p. injection of the
satiety signal cholecystokinin activates NTS neurons, a substan-
tialnumberofwhicharebelievedtobePOMC-ergic(Rinamanet
al.,1998;Fanetal.,2004;Appleyardetal.,2005).Therefore,NTS
POMC neurons may sense short-term satiety signals from vis-
ceral afferents to inhibit feeding behavior rapidly.
What might be the circuit mechanisms underlying the func-
tional disparity between POMC neurons in the ARC and the
NTS? The axonal terminals of ARC POMC neurons mainly ter-
minate in the forebrain, including the paraventricular nucleus,
dorsomedial hypothalamus, lateral hypothalamus, and central
amygdala (Schwartz et al., 2000; Cone, 2005). These areas also
receive strong input from ARC agouti-related protein neurons,
which stimulate appetite and decrease metabolism powerfully
(Aponte et al., 2011; Krashes et al., 2011). By interacting with
agouti-related protein neurons, POMC neurons in the ARC may
influencetheirdownstreamstationsintheforebraintoadjustthe
set point of body weight and energy homeostasis. Conversely,
NTS POMC neurons mainly project to the caudal medulla and
spinal cord (Tsou et al., 1986; Palkovits et al., 1987; Zheng et al.,
2005), where neural circuits may be more directly involved in
executing satiety-trigged feeding suppression. In addition to dis-
tinct axonal projection targets, POMC neurons in the ARC and
NTS differ in numbers. There are 3000 POMC neurons in the
ARC,whereasonly400POMCneuronsarepresentintheNTS
(Hentges et al., 2004; Cone, 2005). Ablation of NTS POMC neu-
ronslacksanobviousbehavioraleffect,possiblybecauseoffunc-
tional compensation by long-term activity of POMC neurons in
the ARC and changes in other components of the feeding circuit
(Pinto et al., 2004).
Our present results may also have clinical implications. Al-
though loss-of-function mutations of the POMC genes are asso-
ciated with early-onset obesity in humans (Krude et al., 1998),
obesity can also be produced by mutations of melanocortin re-
ceptorsordisordersthatareindirectlyrelatedtothecentralmela-
nocortin signaling (Farooqi et al., 2003). Nasal application of
-MSH lacks consistent effects on treating human obesity
(Hallschmid et al., 2004), raising questions about the validity of
melanocortin-based therapeutics. Our present results show that
chronic stimulation of POMC neurons can suppress daily food
intake effectively and reduce body weight mildly. However, obe-
sity can only be induced after 80% of POMC neurons in the
ARC are ablated, suggesting a large degree of redundancy in
melanocortin signaling. Anti-obesity therapeutics based on
melanocortins may require a personalized medical approach.
Nasal application of -MSH may be rendered more effective by
targeting obese persons with severe POMC deficiency.
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